The pyrazoloacridines: approaches to the development of a carcinoma-selective cytotoxic agent.
Jackson
R C
RC
Chemotherapy Department, Parke-Davis Pharmaceutical Research Division, Ann Arbor, Michigan 48105.
Sebolt
J S
JS
Shillis
J L
JL
Leopold
W R
WR
D000166:Acridines / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D015195:Drug Design; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D011720:Pyrazoles / Q000494:pharmacology* / Q000633:toxicity
D000166:Acridines; D000970:Antineoplastic Agents; D011720:Pyrazoles; C064542:NSC 377163; C064541:NSC 366140